Molecular Devices to attend ADME & Predictive Toxicology Europe
News Feb 29, 2012
The SpectraMax® Paradigm® Multi-Mode Microplate Detection Platform is the only user upgradeable microplate reader on the market that allows for real-time system configuration by the user in less than two minutes. This revolution in modularity allows you to read what you want, when you want without compromising your biology. Although your detection needs may change, your equipment can stay the same simply by adding a new detection cartridge. Cartridges include TUNE, Absorbance, HTRF, AlphaScreen® and Fluorescence intensity.
SpectraMax® microplate readers are ideal for increased throughput of early ADME compound profiling assays such as the Transil® Membrane Affinity Assay and Human Serum Albumin Binding Assay. The Membrane Affinity assay provides high-throughput lipophilicity data equivalent to liposome-based methods without the need for ultracentrifugation. The Human Serum Albumin Binding assay provides high-throughput blood protein binding data by measuring the fraction bound to Human Serum Albumin.
Oligonucleotide Drug Producers Report on Drug ImpuritiesNews
A new addition to a series of articles that focus on important topics related to the development of oligonucleotide therapeutics presents an in-depth look at the identification, characterization, and reporting of product-related impurities.READ MORE
Tapeworm Drug Molecule Could Aid Fight Against Parkinson’s DiseaseNews
Researchers have identified a drug molecule within a medicine used to treat tapeworm infections which could lead to new treatments for patients with Parkinson's disease.READ MORE
IDEX Health & Science Announces Acquisition of New Microfluidics CompanyNews
IDEX Health & Science, LLC announced the acquisition of thinXXS Microtechnology that will accelerate growth of its microfluidics consumables business.READ MORE